S1E16 The Joys of Solving Really Hard Problems | Robert Whirley

Being an Engineer · 26 Jun 2020 · 51m · Episode 16

What this episode covers

Robert Whirley, CEO of OurTarika, discusses his career in medical device engineering, highlighting his transition from aerospace to medtech and the importance of solving hard problems. He details the founding of Troy Vascular, explaining how bringing nonlinear finite element simulation from aerospace helped validate designs and secure venture capital by providing confidence beyond just prototypes. Whirley emphasizes focusing on fundamental physics (like using gaskets for sealing) rather than copying existing stent graft solutions, and shares advice on building high-performing teams and communicating effectively with leaders.

Other shows on the same ground, closest first.

  • Let's Combinate · 58m

    005 - “Compassionate Product Development” with Cameron Jones

    Cameron Jones, Co-Founder and CEO of Avasys Medical, discusses his journey from academic research at Vanderbilt, the University of Kentucky, and Johns Hopkins to founding a medical device company. He details the process of identifying unmet clinical needs through direct observation of clinicians, highlighting a specific case where a tourniquet design required 14 prototypes to meet size and safety constraints. Jones also explains his work on catheter interfaces to reduce infection risks and his philosophy on managing conflicts of interest while moonlighting between startups and large manufacturers.

  • Global Medical Device Podcast · 43m

    #381: MedTech Advice from an Accidental Entrepreneur

    Dr. Asha Parekh, CEO and co-founder of Frontline Medical Technologies, explains how she transitioned from a biomedical engineering PhD to an accidental entrepreneur with vascular surgeon Dr. Adam Power. They developed the COBRA-OS, a bleeding control device used in trauma care, military settings, and Formula One race tracks. Parekh discusses the critical role of passion in overcoming challenges, the art of pitching to secure millions in funding, and the importance of founders remaining the ultimate experts on their device's regulatory pathway rather than relying blindly on consultants.

  • Global Medical Device Podcast · 39m

    #455: MedTech Founder 101: Shifting from Corporate to Startup with John Schindler

    John Schindler, CEO of Liquet Medical, discusses the transition from corporate roles at Atrium and Merit Medical to founding a startup, emphasizing the 'novel but simple' philosophy for vascular drug delivery devices. He explains how Liquet leverages its 510(k) clearance for pulmonary embolism treatment while planning an IDE trial, advocating for limited market releases to build strategic enterprise value through intentional clinical data. Schindler also covers the challenges of fundraising, negotiating with regulatory service providers, and the importance of early FDA engagement to avoid timeline resets.

  • Let's Combinate · 1h 30m

    009 - “Cutting Through the Noise” with Charles Ventura

    Charles Ventura, CEO of Hemotek Medical and President of Ventura Solutions, discusses his career transition from biomedical engineering at Baxter Healthcare to founding his own companies. He details the development of the V Needle, a safety device for dialysis to prevent venous needle dislodgement, emphasizing the importance of systems engineering, risk management (ISO 14971), and user-centric design. Ventura also provides strategic advice for early-career engineers, highlighting the necessity of mastering regulatory frameworks like FDA 21 CFR Part 820 and ISO 13485, as well as practical skills in statistics and project management to secure their first roles.

  • Global Medical Device Podcast · 42m

    #473: The MedTech Odyssey: Bridging Academic Science to Series A Success

    Jordi Martorell, CEO and co-founder of Aortyx, discusses his journey from mapping arterial blood flow at the Harvard-MIT Biomedical Engineering Center to raising a Series A for his Class III medical device company. He explains how Aortyx sustained its multi-year development of bioresorbable endovascular patches for aortic dissection by leveraging friends-and-family rounds, Capital Cell equity crowdfunding, and European Innovation Council (EIC) grants. Martorell details the structural challenges of managing a cap table with hundreds of retail investors via syndication and SPVs to maintain clean negotiation lines for institutional VCs. He also reflects on the realities of closing a Series A in a non-traditional VC hub, facing post-pandemic inflation, and the critical importance of resilience and visibility at conferences like LSI.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Being an Engineer. The episode itself belongs to its publisher.